Glaucoma, the “Silent Thief of Sight”: Why 2026’s Screening Guidance Matters So Much for South Africans

No pain. No redness. No warning that anything is wrong, right up until a patient notices they’ve bumped into a doorframe they swear wasn’t there, or a driver realises they never saw the car pulling out from the side. This is how glaucoma usually announces itself in South Africa: not with a symptom, but with a gap in vision that’s already permanent. It’s why eye care professionals have long called it “the silent thief of sight,” and why 2026’s screening data and treatment updates make a stronger case than ever for regular, proactive testing rather than waiting for a problem to announce itself.

What glaucoma actually is

Glaucoma is not one single disease but a group of conditions that damage the optic nerve, the cable that carries visual information from the eye to the brain. In the most common form, pressure inside the eye gradually rises because fluid isn’t draining properly, and that pressure slowly damages nerve fibres over months and years. Because the earliest vision loss happens at the outer edges of your visual field, not in the centre where you’re paying attention, the brain quietly fills in the gaps and most people don’t notice anything is wrong until a meaningful portion of their vision, and their optic nerve, is already gone. That damage cannot be reversed. It can only be stopped from getting worse, which is precisely why timing matters so much.

Why South Africans have more at stake

Two things make glaucoma an especially urgent issue locally rather than a generic health warning.

The first is awareness, or the lack of it. According to South African Glaucoma Society figures highlighted for World Glaucoma Week this year, only around one in twenty South Africans who have glaucoma are actually aware they have it, and roughly half of patients will already be blind in one eye by the time they see an eye care specialist. That isn’t a failure of treatment — glaucoma is very manageable once caught — it’s a failure of detection, and detection only happens when people who feel perfectly fine still come in for a proper check.

The second is genetics and physiology. A growing body of research, including a 2026 review of primary open-angle glaucoma in people of African descent, confirms what earlier population studies first flagged: glaucoma is roughly four to five times more common in people of African ancestry than in white populations, tends to appear at a younger age, and progresses more aggressively once it starts. Contributing factors identified in this research include thinner average corneal thickness (which can cause standard pressure tests to under-read the true risk) and higher average intraocular pressure. Across sub-Saharan Africa, glaucoma is already responsible for roughly 15 out of every 100 cases of blindness. For the majority-Black patient population Jason Stander Optometrists serves in Polokwane and across Limpopo, this isn’t an abstract statistic. It’s a direct, practical reason to treat glaucoma screening as routine rather than optional, starting earlier than many people assume.

What’s new in glaucoma care in 2026

Glaucoma management has moved well past “one drop, once a day, forever.” Recent developments getting attention at major glaucoma and optometry conferences this year include:

Sustained-release medication implants. Rather than relying on patients remembering a daily drop, tiny implants placed during a routine procedure now release pressure-lowering medication steadily over months. Some newer versions approved this year allow for annual re-treatment, directly addressing one of glaucoma management’s biggest real-world failure points: people simply forgetting or stopping their drops.

Laser treatment as a genuine first-line option. Selective laser trabeculoplasty, a quick in-office laser procedure that improves the eye’s natural drainage, is increasingly being offered before drops rather than only after them. Recent trial data shows a large majority of treated eyes maintaining healthy pressure without needing daily medication or surgery for years afterward.

Minimally invasive glaucoma surgery (MIGS). For patients needing more than drops or laser, a new generation of tiny stents and drainage devices, some now placed at the same time as cataract surgery, create new outflow pathways for fluid with far less trauma to the eye than traditional glaucoma surgery required.

Smarter diagnostics. Optical coherence tomography (OCT) scanning, which produces a detailed cross-sectional map of the optic nerve and retina, combined with AI-assisted analysis of scan patterns, is helping optometrists detect the earliest structural changes in the optic nerve well before they show up as a noticeable gap on a visual field test. Home tonometry devices are also starting to give a fuller picture of how eye pressure fluctuates throughout the day, rather than relying on a single reading taken at one moment in the consulting room.

Who should be screened, and how often

Given how symptom-free early glaucoma is, the recommended testing schedule isn’t based on how your eyes feel — it’s based on age and risk: under 40, with no other risk factors, every two to four years; between 40 and 60, every two to three years; over 60, every year. That schedule moves considerably earlier if you have a family history of glaucoma, are of African descent, have diabetes, high blood pressure or cardiovascular disease, are significantly near-sighted, or have previously had an eye injury or eye surgery. If more than one of these applies to you, it’s worth raising directly with your optometrist rather than waiting for your next routine visit to come around on its own.

What this means for your next eye examination

A comprehensive eye examination at Jason Stander Optometrists includes intraocular pressure measurement and optic nerve assessment as standard, not as an add-on reserved for patients already showing symptoms, because with glaucoma, symptoms are the thing you’re trying to avoid waiting for. Given how strongly local risk factors stack up for many patients in Polokwane and across Limpopo, that screening is treated as a core part of every adult eye test here, not an optional extra.

Book an eye examination with our team at Shop 7, Cycad Centre, Bendor, Polokwane. If it’s been more than two or three years since your last full check, or if glaucoma runs in your family, there’s no better time than now, before any vision is lost, to find out where you stand.